Biotechnology
The Biotechnology industry has a total of 591 stocks, with a combined market cap of $1.06 trillion and total revenue of $110.21 billion.
Market Cap
1.06T
Revenue
110.21B
Profits
-42.06B
PE Ratio
n/a
Profit Margin
-38.16%
Dividend Yield
0.04%
591 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 115.50B | 0.15% | 382,469 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 77.94B | 0.60% | 191,669 | 14.34B |
| 3 | ARGX | argenx SE | 42.24B | 2.80% | 260,784 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.59B | -1.95% | 653,801 | 3.71B |
| 5 | INSM | Insmed Incorporated | 30.98B | 5.69% | 2,289,263 | 606.42M |
| 6 | ONC | BeOne Medicines AG | 30.42B | -0.31% | 115,951 | 5.34B |
| 7 | BNTX | BioNTech SE | 22.58B | 0.66% | 767,171 | 3.37B |
| 8 | MRNA | Moderna, Inc. | 20.51B | 1.07% | 3,632,130 | 1.94B |
| 9 | ROIV | Roivant Sciences Ltd. | 20.15B | 1.66% | 2,402,432 | 13.31M |
| 10 | RPRX | Royalty Pharma plc | 19.57B | 0.73% | 1,690,243 | 2.38B |
| 11 | RVMD | Revolution Medicines, Inc. | 19.18B | 1.04% | 658,388 | - |
| 12 | INCY | Incyte Corporation | 18.08B | 0.08% | 732,644 | 5.14B |
| 13 | GMAB | Genmab A/S | 15.80B | 2.91% | 995,748 | 3.72B |
| 14 | BBIO | BridgeBio Pharma, Inc. | 13.57B | 2.14% | 716,442 | 502.08M |
| 15 | ASND | Ascendis Pharma A/S | 13.38B | -1.78% | 226,867 | 845.52M |
| 16 | SMMT | Summit Therapeutics Inc. | 12.28B | 2.13% | 1,055,784 | - |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 11.72B | -0.07% | 921,922 | 943.71M |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 11.23B | 0.97% | 262,948 | 4.27B |
| 19 | EXEL | Exelixis, Inc. | 10.82B | 0.99% | 956,717 | 2.32B |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 10.51B | 0.92% | 974,192 | 3.22B |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.32B | 2.00% | 92,684 | 958.40M |
| 22 | IBRX | ImmunityBio, Inc. | 9.53B | 9.45% | 19,036,605 | 113.29M |
| 23 | ABVX | ABIVAX Société Anonyme | 9.05B | -3.32% | 930,649 | 6.23M |
| 24 | PRAX | Praxis Precision Medicines, Inc. | 8.37B | 0.77% | 374,618 | 7.46M |
| 25 | TECH | Bio-Techne Corporation | 8.17B | 1.42% | 778,150 | 1.22B |
| 26 | PCVX | Vaxcyte, Inc. | 8.00B | 1.55% | 470,496 | - |
| 27 | AXSM | Axsome Therapeutics, Inc. | 7.99B | -0.42% | 218,683 | 638.50M |
| 28 | ARWR | Arrowhead Pharmaceuticals, Inc. | 7.98B | 1.17% | 890,635 | 1.09B |
| 29 | CYTK | Cytokinetics, Incorporated | 7.54B | -0.81% | 662,285 | 88.04M |
| 30 | NUVL | Nuvalent, Inc. | 7.46B | 0.14% | 234,847 | - |
| 31 | HALO | Halozyme Therapeutics, Inc. | 7.45B | -0.54% | 548,962 | 1.40B |
| 32 | KRYS | Krystal Biotech, Inc. | 7.32B | -0.55% | 168,362 | 389.13M |
| 33 | ACLX | Arcellx, Inc. | 6.70B | -0.17% | 683,523 | 22.29M |
| 34 | PTGX | Protagonist Therapeutics, Inc. | 6.31B | 0.06% | 289,152 | 46.02M |
| 35 | KYMR | Kymera Therapeutics, Inc. | 6.26B | -1.51% | 357,071 | 39.21M |
| 36 | BLTE | Belite Bio, Inc | 5.98B | -1.61% | 96,305 | - |
| 37 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.76B | -3.49% | 471,489 | 189.76M |
| 38 | COGT | Cogent Biosciences, Inc. | 5.75B | 6.08% | 1,193,067 | - |
| 39 | APGE | Apogee Therapeutics, Inc. | 5.55B | 20.99% | 2,659,164 | - |
| 40 | PTCT | PTC Therapeutics, Inc. | 5.50B | 1.75% | 282,376 | 1.73B |
| 41 | CGON | CG Oncology, Inc. | 5.47B | -0.37% | 772,079 | 4.04M |
| 42 | CAI | Caris Life Sciences, Inc. | 5.43B | 4.43% | 1,102,283 | 812.03M |
| 43 | MIRM | Mirum Pharmaceuticals, Inc. | 5.38B | 0.70% | 433,812 | 521.31M |
| 44 | XENE | Xenon Pharmaceuticals Inc. | 5.29B | 0.86% | 616,923 | 7.50M |
| 45 | SRRK | Scholar Rock Holding Corporation | 5.05B | -1.57% | 804,112 | - |
| 46 | IMVT | Immunovant, Inc. | 4.98B | 6.57% | 909,798 | - |
| 47 | CELC | Celcuity Inc. | 4.97B | 1.23% | 273,341 | - |
| 48 | TGTX | TG Therapeutics, Inc. | 4.84B | 0.73% | 1,124,973 | 616.29M |
| 49 | FOLD | Amicus Therapeutics, Inc. | 4.52B | -0.17% | 1,571,492 | 634.21M |
| 50 | CRSP | CRISPR Therapeutics AG | 4.52B | 1.90% | 913,662 | 3.51M |
| 51 | ERAS | Erasca, Inc. | 4.52B | -0.45% | 2,697,589 | - |
| 52 | TERN | Terns Pharmaceuticals, Inc. | 4.50B | 3.20% | 2,378,362 | - |
| 53 | LGND | Ligand Pharmaceuticals Incorporated | 4.07B | -0.46% | 134,859 | 268.09M |
| 54 | VKTX | Viking Therapeutics, Inc. | 3.83B | 2.43% | 1,316,693 | - |
| 55 | ACAD | ACADIA Pharmaceuticals Inc. | 3.63B | 2.60% | 539,744 | 1.07B |
| 56 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.62B | -2.92% | 1,300,376 | 7.70M |
| 57 | CORT | Corcept Therapeutics Incorporated | 3.61B | -2.05% | 738,841 | 761.41M |
| 58 | CNTA | Centessa Pharmaceuticals plc | 3.55B | -2.48% | 800,418 | 15.00M |
| 59 | GPCR | Structure Therapeutics Inc. | 3.51B | 2.10% | 988,251 | - |
| 60 | DNTH | Dianthus Therapeutics, Inc. | 3.51B | 1.62% | 773,922 | 2.04M |
| 61 | NAMS | NewAmsterdam Pharma Company N.V. | 3.44B | 3.42% | 498,973 | 22.50M |
| 62 | SYRE | Spyre Therapeutics, Inc. | 3.40B | 4.95% | 394,116 | - |
| 63 | ADMA | ADMA Biologics, Inc. | 3.39B | -0.49% | 2,524,945 | 510.17M |
| 64 | DNLI | Denali Therapeutics Inc. | 3.33B | 4.16% | 948,518 | - |
| 65 | LEGN | Legend Biotech Corporation | 3.21B | -0.17% | 883,494 | 1.03B |
| 66 | EWTX | Edgewise Therapeutics, Inc. | 3.16B | 1.51% | 377,900 | - |
| 67 | TLX | Telix Pharmaceuticals Limited | 3.10B | 4.57% | 174,581 | 803.79M |
| 68 | ALMS | Alumis Inc. | 3.03B | -4.79% | 1,123,882 | 24.05M |
| 69 | DYN | Dyne Therapeutics, Inc. | 2.95B | 1.71% | 1,253,817 | - |
| 70 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.87B | 3.12% | 381,771 | 588.99M |
| 71 | VERA | Vera Therapeutics, Inc. | 2.86B | -1.01% | 358,192 | - |
| 72 | VRDN | Viridian Therapeutics, Inc. | 2.86B | 3.71% | 668,579 | 70.85M |
| 73 | IDYA | IDEAYA Biosciences, Inc. | 2.82B | -1.82% | 1,281,496 | 218.71M |
| 74 | TNGX | Tango Therapeutics, Inc. | 2.77B | - | 1,432,774 | 62.38M |
| 75 | ARQT | Arcutis Biotherapeutics, Inc. | 2.76B | 0.05% | 433,928 | 376.07M |
| 76 | TARS | Tarsus Pharmaceuticals, Inc. | 2.73B | -0.68% | 248,099 | 451.36M |
| 77 | RCUS | Arcus Biosciences, Inc. | 2.72B | 0.32% | 355,374 | 247.00M |
| 78 | BEAM | Beam Therapeutics Inc. | 2.59B | 3.21% | 783,884 | 139.74M |
| 79 | TVTX | Travere Therapeutics, Inc. | 2.59B | 4.43% | 658,594 | 490.73M |
| 80 | IMNM | Immunome, Inc. | 2.34B | 3.40% | 515,140 | 6.94M |
| 81 | MAZE | Maze Therapeutics, Inc. | 2.30B | -0.42% | 292,814 | 2.50M |
| 82 | MANE | Veradermics, Incorporated | 2.30B | 4.49% | 112,563 | - |
| 83 | IRON | Disc Medicine, Inc. | 2.27B | 2.05% | 194,692 | - |
| 84 | APLS | Apellis Pharmaceuticals, Inc. | 2.26B | 2.73% | 1,243,130 | 1.00B |
| 85 | DAWN | Day One Biopharmaceuticals, Inc. | 2.21B | -0.33% | 833,614 | 158.18M |
| 86 | WVE | Wave Life Sciences Ltd. | 2.17B | -2.13% | 2,148,960 | 42.73M |
| 87 | SNDX | Syndax Pharmaceuticals, Inc. | 2.16B | 1.11% | 517,353 | 172.35M |
| 88 | CLDX | Celldex Therapeutics, Inc. | 2.16B | 5.05% | 955,771 | 1.55M |
| 89 | ADPT | Adaptive Biotechnologies Corporation | 2.11B | 1.10% | 572,696 | 276.98M |
| 90 | GLPG | Galapagos NV | 2.09B | -0.78% | 56,983 | 1.31B |
| 91 | NKTR | Nektar Therapeutics | 2.09B | 1.01% | 455,219 | 55.23M |
| 92 | ORKA | Oruka Therapeutics, Inc. | 2.04B | 5.99% | 344,551 | - |
| 93 | STOK | Stoke Therapeutics, Inc. | 2.02B | 1.76% | 207,760 | 184.42M |
| 94 | AAPG | Ascentage Pharma Group International | 2.01B | 13.40% | 13,283 | 54.52M |
| 95 | TYRA | Tyra Biosciences, Inc. | 1.97B | -1.78% | 539,411 | - |
| 96 | AUPH | Aurinia Pharmaceuticals Inc. | 1.96B | 5.35% | 1,604,705 | 283.06M |
| 97 | MLYS | Mineralys Therapeutics, Inc. | 1.96B | -1.20% | 660,042 | - |
| 98 | ZLAB | Zai Lab Limited | 1.96B | -2.21% | 478,881 | 460.16M |
| 99 | RARE | Ultragenyx Pharmaceutical Inc. | 1.92B | - | 906,300 | 673.00M |
| 100 | MESO | Mesoblast Limited | 1.90B | 2.68% | 89,166 | 65.38M |
| 101 | ELVN | Enliven Therapeutics, Inc. | 1.85B | 6.36% | 493,682 | - |
| 102 | SRPT | Sarepta Therapeutics, Inc. | 1.83B | 4.55% | 1,110,139 | 2.20B |
| 103 | ANAB | AnaptysBio, Inc. | 1.82B | 1.55% | 196,222 | 234.60M |
| 104 | DFTX | Definium Therapeutics, Inc. | 1.82B | -0.92% | 643,424 | - |
| 105 | OCUL | Ocular Therapeutix, Inc. | 1.81B | 1.89% | 2,202,401 | 51.95M |
| 106 | RLAY | Relay Therapeutics, Inc. | 1.79B | 1.31% | 1,139,225 | 15.36M |
| 107 | ZYME | Zymeworks Inc. | 1.77B | 3.17% | 301,773 | 105.97M |
| 108 | RXRX | Recursion Pharmaceuticals, Inc. | 1.72B | 0.62% | 7,465,342 | 74.68M |
| 109 | CAPR | Capricor Therapeutics, Inc. | 1.70B | 1.82% | 732,931 | 11.13M |
| 110 | SLNO | Soleno Therapeutics, Inc. | 1.67B | -2.35% | 491,823 | 190.41M |
| 111 | SION | Sionna Therapeutics, Inc. | 1.66B | 1.62% | 187,798 | - |
| 112 | VCEL | Vericel Corporation | 1.65B | 3.44% | 282,412 | 276.26M |
| 113 | AGIO | Agios Pharmaceuticals, Inc. | 1.64B | 0.18% | 253,783 | 54.03M |
| 114 | INVA | Innoviva, Inc. | 1.62B | 0.83% | 266,243 | 411.33M |
| 115 | HRMY | Harmony Biosciences Holdings, Inc. | 1.61B | 0.51% | 327,044 | 868.45M |
| 116 | GENB | Generate Biomedicines, Inc. | 1.59B | 1.47% | 148,008 | 31.89M |
| 117 | NVAX | Novavax, Inc. | 1.58B | 0.52% | 2,334,559 | 1.12B |
| 118 | IMCR | Immunocore Holdings plc | 1.55B | 2.34% | 154,025 | 400.02M |
| 119 | IOVA | Iovance Biotherapeutics, Inc. | 1.54B | 1.36% | 5,337,964 | 263.50M |
| 120 | NUVB | Nuvation Bio Inc. | 1.54B | 4.98% | 2,924,081 | 62.90M |
| 121 | NTLA | Intellia Therapeutics, Inc. | 1.53B | 0.93% | 2,036,454 | 67.67M |
| 122 | NRIX | Nurix Therapeutics, Inc. | 1.52B | 2.22% | 479,400 | 83.98M |
| 123 | NBTX | Nanobiotix S.A. | 1.48B | 5.55% | 86,538 | 11.93M |
| 124 | OCS | Oculis Holding AG | 1.47B | -0.04% | 166,393 | 1.51M |
| 125 | PHVS | Pharvaris N.V. | 1.41B | -0.81% | 96,971 | - |
| 126 | MBX | MBX Biosciences, Inc. | 1.40B | 2.55% | 261,997 | - |
| 127 | PVLA | Palvella Therapeutics, Inc. | 1.39B | 4.24% | 168,730 | - |
| 128 | TRVI | Trevi Therapeutics, Inc. | 1.39B | 1.79% | 1,176,906 | - |
| 129 | BHVN | Biohaven Ltd. | 1.35B | 0.67% | 562,413 | - |
| 130 | DMRA | Damora Therapeutics, Inc. | 1.34B | 22.52% | 187,948 | - |
| 131 | RAPP | Rapport Therapeutics, Inc. | 1.31B | 1.26% | 109,222 | - |
| 132 | ARDX | Ardelyx, Inc. | 1.30B | 0.19% | 2,088,679 | 407.32M |
| 133 | TSHA | Taysha Gene Therapies, Inc. | 1.29B | 1.82% | 850,568 | 9.77M |
| 134 | IMTX | Immatics N.V. | 1.27B | 0.11% | 118,651 | 56.67M |
| 135 | ATAI | AtaiBeckley Inc. | 1.25B | -1.72% | 2,306,151 | 4.09M |
| 136 | VIR | Vir Biotechnology, Inc. | 1.24B | -2.20% | 1,115,688 | 68.56M |
| 137 | OLMA | Olema Pharmaceuticals, Inc. | 1.23B | 0.28% | 641,520 | - |
| 138 | MLTX | MoonLake Immunotherapeutics | 1.20B | 3.01% | 537,282 | - |
| 139 | ZBIO | Zenas BioPharma, Inc. | 1.20B | -6.50% | 1,183,498 | 10.00M |
| 140 | GLUE | Monte Rosa Therapeutics, Inc. | 1.19B | -4.70% | 473,080 | 123.67M |
| 141 | KOD | Kodiak Sciences Inc. | 1.18B | 0.13% | 251,487 | - |
| 142 | PGEN | Precigen, Inc. | 1.16B | -0.15% | 1,463,648 | 6.31M |
| 143 | CRVS | Corvus Pharmaceuticals, Inc. | 1.15B | 3.15% | 596,853 | - |
| 144 | ORIC | ORIC Pharmaceuticals, Inc. | 1.15B | 2.33% | 725,671 | - |
| 145 | TVGN | Tevogen Bio Holdings Inc. | 1.11B | 5.17% | 22,479 | - |
| 146 | EYPT | EyePoint, Inc. | 1.08B | -2.04% | 443,704 | 31.37M |
| 147 | SEPN | Septerna, Inc. | 1.08B | -0.70% | 113,256 | 45.95M |
| 148 | PHAR | Pharming Group N.V. | 1.08B | 2.21% | 28,026 | 376.13M |
| 149 | ABCL | AbCellera Biologics Inc. | 1.05B | 1.62% | 1,543,448 | 75.13M |
| 150 | SVRA | Savara Inc. | 1.03B | 1.81% | 1,112,147 | - |
| 151 | BCAX | Bicara Therapeutics Inc. | 1.03B | 1.79% | 166,025 | - |
| 152 | GERN | Geron Corporation | 1.01B | 8.22% | 14,843,781 | 183.88M |
| 153 | AVBP | ArriVent BioPharma, Inc. | 987.91M | 1.50% | 311,387 | - |
| 154 | AKTS | Aktis Oncology, Inc. | 962.73M | 3.56% | 352,294 | 5.56M |
| 155 | SLS | SELLAS Life Sciences Group, Inc. | 962.56M | 12.61% | 7,239,545 | - |
| 156 | QURE | uniQure N.V. | 950.45M | -5.53% | 1,255,142 | 16.10M |
| 157 | XERS | Xeris Biopharma Holdings, Inc. | 950.10M | 1.29% | 616,285 | 291.85M |
| 158 | INBX | Inhibrx Biosciences, Inc. | 939.23M | 5.55% | 103,348 | 1.30M |
| 159 | FTRE | Fortrea Holdings Inc. | 924.72M | 3.78% | 513,737 | 2.72B |
| 160 | CMPX | Compass Therapeutics, Inc. | 908.54M | -2.04% | 719,967 | 850.00K |
| 161 | XNCR | Xencor, Inc. | 892.53M | 0.33% | 725,146 | 125.58M |
| 162 | SGP | SpyGlass Pharma, Inc. | 871.25M | 0.58% | 62,510 | - |
| 163 | EVMN | Evommune, Inc. | 859.04M | 2.23% | 101,173 | 13.00M |
| 164 | PHAT | Phathom Pharmaceuticals, Inc. | 856.54M | -3.03% | 358,029 | 175.11M |
| 165 | JANX | Janux Therapeutics, Inc. | 852.25M | -0.36% | 355,761 | 10.00M |
| 166 | IVA | Inventiva S.A. | 850.21M | 5.71% | 151,418 | 19.93M |
| 167 | KALV | KalVista Pharmaceuticals, Inc. | 844.63M | -1.71% | 300,446 | 1.43M |
| 168 | URGN | UroGen Pharma Ltd. | 843.66M | -1.65% | 202,488 | 109.79M |
| 169 | SANA | Sana Biotechnology, Inc. | 837.96M | 0.96% | 789,009 | - |
| 170 | GHRS | GH Research PLC | 837.09M | -3.40% | 134,659 | - |
| 171 | ABUS | Arbutus Biopharma Corporation | 834.69M | 0.71% | 2,148,548 | 14.08M |
| 172 | ANL | Adlai Nortye Ltd. | 807.01M | -1.49% | 122,771 | -1.35M |
| 173 | CGEM | Cullinan Therapeutics, Inc. | 786.84M | 2.04% | 742,750 | - |
| 174 | SPRY | ARS Pharmaceuticals, Inc. | 767.57M | -5.39% | 980,817 | 84.28M |
| 175 | TBPH | Theravance Biopharma, Inc. | 760.55M | 3.07% | 503,625 | 107.46M |
| 176 | CTMX | CytomX Therapeutics, Inc. | 759.88M | 0.34% | 2,564,180 | 76.20M |
| 177 | OMER | Omeros Corporation | 758.63M | -2.73% | 628,008 | - |
| 178 | MPLT | MapLight Therapeutics, Inc. | 747.58M | -2.45% | 63,924 | - |
| 179 | MNKD | MannKind Corporation | 747.14M | -1.82% | 2,802,158 | 348.97M |
| 180 | KURA | Kura Oncology, Inc. | 737.55M | 1.09% | 663,161 | 67.48M |
| 181 | DRUG | Bright Minds Biosciences Inc. | 713.65M | 3.11% | 81,652 | - |
| 182 | SLDB | Solid Biosciences Inc. | 706.45M | 2.13% | 619,451 | - |
| 183 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 704.29M | 1.38% | 63,997 | - |
| 184 | JBIO | Jade Biosciences, Inc. | 700.78M | 1.50% | 153,588 | - |
| 185 | LXRX | Lexicon Pharmaceuticals, Inc. | 696.95M | 5.45% | 1,175,764 | 49.80M |
| 186 | GYRE | Gyre Therapeutics, Inc. | 696.20M | 6.85% | 103,715 | 116.59M |
| 187 | OCGN | Ocugen, Inc. | 678.75M | 1.47% | 9,447,664 | 4.41M |
| 188 | ARVN | Arvinas, Inc. | 670.95M | -4.11% | 453,505 | 262.60M |
| 189 | PRME | Prime Medicine, Inc. | 664.43M | 4.55% | 1,257,115 | 4.63M |
| 190 | ANRO | Alto Neuroscience, Inc. | 643.70M | -6.15% | 361,072 | - |
| 191 | ANNX | Annexon, Inc. | 641.23M | 4.89% | 1,119,262 | - |
| 192 | DRTS | Alpha Tau Medical Ltd. | 638.07M | 2.55% | 169,847 | - |
| 193 | EIKN | Eikon Therapeutics, Inc. | 635.40M | -0.42% | 107,145 | - |
| 194 | MDXG | MiMedx Group, Inc. | 633.64M | 3.52% | 415,419 | 418.63M |
| 195 | DSGN | Design Therapeutics, Inc. | 627.82M | -1.26% | 137,784 | - |
| 196 | ALLO | Allogene Therapeutics, Inc. | 621.63M | 23.19% | 8,286,838 | 22.00K |
| 197 | MGTX | MeiraGTx Holdings plc | 611.33M | 5.49% | 158,324 | 27.42M |
| 198 | RLMD | Relmada Therapeutics, Inc. | 606.27M | -4.78% | 727,286 | - |
| 199 | AGMB | AgomAb Therapeutics NV | 601.90M | 1.31% | 89,479 | - |
| 200 | LBRX | LB Pharmaceuticals Inc | 601.61M | 1.06% | 55,674 | - |
| 201 | REPL | Replimune Group, Inc. | 570.58M | -1.00% | 810,184 | - |
| 202 | VALN | Valneva SE | 562.73M | -37.11% | 604,665 | 205.07M |
| 203 | TECX | Tectonic Therapeutic, Inc. | 557.67M | -0.60% | 90,855 | - |
| 204 | ZVRA | Zevra Therapeutics, Inc. | 548.37M | 1.19% | 395,979 | 106.47M |
| 205 | DBVT | DBV Technologies S.A. | 538.83M | 3.12% | 150,817 | 5.50M |
| 206 | ZURA | Zura Bio Limited | 530.86M | 1.73% | 293,826 | - |
| 207 | ADCT | ADC Therapeutics SA | 517.71M | 5.57% | 345,420 | 81.36M |
| 208 | CRMD | CorMedix Inc. | 500.78M | 1.36% | 724,148 | 311.71M |
| 209 | ENGN | enGene Holdings Inc. | 498.40M | 3.19% | 93,362 | - |
| 210 | RIGL | Rigel Pharmaceuticals, Inc. | 489.74M | 2.12% | 104,870 | 294.28M |
| 211 | LRMR | Larimar Therapeutics, Inc. | 486.17M | 4.23% | 1,092,064 | - |
| 212 | PRTA | Prothena Corporation plc | 480.73M | 2.06% | 292,483 | 9.68M |
| 213 | VSTM | Verastem, Inc. | 475.19M | -2.17% | 1,094,286 | 30.91M |
| 214 | RCKT | Rocket Pharmaceuticals, Inc. | 467.93M | 4.11% | 2,122,818 | - |
| 215 | UPB | Upstream Bio, Inc. | 465.81M | -0.58% | 401,093 | 2.80M |
| 216 | CTNM | Contineum Therapeutics, Inc. | 463.53M | 1.68% | 412,290 | - |
| 217 | FDMT | 4D Molecular Therapeutics, Inc. | 463.29M | 5.40% | 304,832 | 85.21M |
| 218 | FULC | Fulcrum Therapeutics, Inc. | 458.88M | 1.77% | 465,621 | 80.00M |
| 219 | YDES | YD Bio Limited | 457.08M | 19.05% | 18,453 | 510.36K |
| 220 | ASMB | Assembly Biosciences, Inc. | 456.93M | 1.21% | 58,638 | 72.30M |
| 221 | LYEL | Lyell Immunopharma, Inc. | 456.24M | 2.38% | 84,445 | 36.00K |
| 222 | MRVI | Maravai LifeSciences Holdings, Inc. | 452.32M | 3.69% | 1,368,849 | 185.74M |
| 223 | AVIR | Atea Pharmaceuticals, Inc. | 450.15M | -0.18% | 248,945 | - |
| 224 | ALT | Altimmune, Inc. | 450.04M | 3.59% | 2,401,991 | 41.00K |
| 225 | TRDA | Entrada Therapeutics, Inc. | 445.82M | 2.96% | 158,637 | 25.42M |
| 226 | NAUT | Nautilus Biotechnology, Inc. | 442.69M | 15.67% | 755,363 | - |
| 227 | ABSI | Absci Corporation | 441.34M | -0.84% | 2,692,227 | 2.82M |
| 228 | EPRX | Eupraxia Pharmaceuticals Inc. | 438.91M | 3.80% | 228,796 | - |
| 229 | STTK | Shattuck Labs, Inc. | 437.26M | -1.77% | 732,615 | 1.00M |
| 230 | RGNX | REGENXBIO Inc. | 435.61M | 4.20% | 339,976 | 170.44M |
| 231 | ACRS | Aclaris Therapeutics, Inc. | 431.73M | -2.98% | 904,874 | 7.83M |
| 232 | IVVD | Invivyd, Inc. | 422.48M | 8.33% | 1,853,092 | 53.43M |
| 233 | VNDA | Vanda Pharmaceuticals Inc. | 418.48M | -0.56% | 1,992,896 | 216.11M |
| 234 | AURA | Aura Biosciences, Inc. | 418.17M | 0.53% | 114,150 | - |
| 235 | AVXL | Anavex Life Sciences Corp. | 415.17M | 10.34% | 1,460,873 | - |
| 236 | NMRA | Neumora Therapeutics, Inc. | 410.20M | -2.19% | 325,623 | - |
| 237 | DNA | Ginkgo Bioworks Holdings, Inc. | 406.58M | 2.83% | 713,210 | 170.16M |
| 238 | LXEO | Lexeo Therapeutics, Inc. | 405.44M | -1.68% | 432,705 | - |
| 239 | IPSC | Century Therapeutics, Inc. | 403.48M | -7.23% | 975,939 | 109.16M |
| 240 | DMAC | DiaMedica Therapeutics Inc. | 382.25M | 8.58% | 187,426 | - |
| 241 | BNTC | Benitec Biopharma Inc. | 378.58M | 0.36% | 61,599 | - |
| 242 | NAGE | Niagen Bioscience, Inc. | 377.98M | 1.29% | 446,080 | 129.42M |
| 243 | MNPR | Monopar Therapeutics Inc. | 375.56M | 1.79% | 92,509 | - |
| 244 | XFOR | X4 Pharmaceuticals, Inc. | 375.50M | -3.50% | 232,907 | 35.11M |
| 245 | AUTL | Autolus Therapeutics plc | 373.93M | 2.55% | 895,752 | 51.13M |
| 246 | PRTC | PureTech Health plc | 372.15M | -2.52% | 2,648 | 6.39M |
| 247 | ENTA | Enanta Pharmaceuticals, Inc. | 367.97M | 1.36% | 54,794 | 66.98M |
| 248 | CADL | Candel Therapeutics, Inc. | 365.50M | 0.40% | 512,003 | - |
| 249 | LCTX | Lineage Cell Therapeutics, Inc. | 363.67M | 0.69% | 1,135,035 | 14.56M |
| 250 | XOMA | XOMA Royalty Corporation | 356.93M | 4.42% | 44,818 | 52.15M |
| 251 | LENZ | LENZ Therapeutics, Inc. | 350.76M | 6.97% | 783,413 | 17.50M |
| 252 | KYTX | Kyverna Therapeutics, Inc. | 345.55M | -0.63% | 373,872 | - |
| 253 | GLSI | Greenwich LifeSciences, Inc. | 344.01M | 3.03% | 85,713 | - |
| 254 | OVID | Ovid Therapeutics Inc. | 331.66M | -4.01% | 2,556,873 | 6.61M |
| 255 | IMRX | Immuneering Corporation | 331.02M | 1.99% | 493,007 | - |
| 256 | PEPG | PepGen Inc. | 328.99M | 1.28% | 260,395 | - |
| 257 | IRD | Opus Genetics, Inc. | 327.29M | 4.78% | 449,779 | 14.20M |
| 258 | PBYI | Puma Biotechnology, Inc. | 316.96M | 1.80% | 123,029 | 228.37M |
| 259 | CLYM | Climb Bio, Inc. | 315.75M | 8.18% | 301,097 | - |
| 260 | PALI | Palisade Bio, Inc. | 313.52M | - | 1,230,325 | - |
| 261 | AVTX | Avalo Therapeutics, Inc. | 311.75M | 1.94% | 1,769,783 | 59.00K |
| 262 | FBRX | Forte Biosciences, Inc. | 308.85M | 4.91% | 55,091 | - |
| 263 | CABA | Cabaletta Bio, Inc. | 306.14M | -6.46% | 2,573,073 | - |
| 264 | NBP | NovaBridge Biosciences | 304.37M | 3.13% | 210,652 | - |
| 265 | NGNE | Neurogene Inc. | 304.22M | 3.10% | 42,129 | 925.00K |
| 266 | CBIO | Crescent Biopharma, Inc. | 303.95M | 1.19% | 60,245 | 10.84M |
| 267 | BCYC | Bicycle Therapeutics plc | 302.53M | -0.23% | 495,231 | 72.59M |
| 268 | FHTX | Foghorn Therapeutics Inc. | 301.13M | 2.60% | 122,360 | 30.91M |
| 269 | ARMP | Armata Pharmaceuticals, Inc. | 300.45M | -1.43% | 22,460 | 5.05M |
| 270 | IMMX | Immix Biopharma, Inc. | 295.15M | -3.51% | 439,377 | - |
| 271 | ACIU | AC Immune SA | 289.04M | -0.35% | 71,079 | 4.51M |
| 272 | NERV | Minerva Neurosciences, Inc. | 283.45M | -13.13% | 220,549 | - |
| 273 | TARA | Protara Therapeutics, Inc. | 280.43M | -0.48% | 636,572 | - |
| 274 | ALXO | ALX Oncology Holdings Inc. | 280.33M | -2.29% | 193,226 | - |
| 275 | OBIO | Orchestra BioMed Holdings, Inc. | 277.39M | 2.16% | 79,244 | 33.48M |
| 276 | CNTX | Context Therapeutics Inc. | 274.72M | 3.82% | 315,329 | - |
| 277 | PROK | ProKidney Corp. | 272.53M | -0.52% | 364,468 | 893.00K |
| 278 | SLN | Silence Therapeutics plc | 266.40M | -8.59% | 241,407 | 559.00K |
| 279 | OABI | OmniAb, Inc. | 259.88M | 2.57% | 102,788 | 18.67M |
| 280 | CAMP | Camp4 Therapeutics Corporation | 255.96M | -1.40% | 52,032 | 3.50M |
| 281 | CCCC | C4 Therapeutics, Inc. | 255.17M | -3.15% | 1,406,541 | 35.95M |
| 282 | PLYX | Polaryx Therapeutics, Inc. | 254.23M | -3.07% | 63,193 | - |
| 283 | ABEO | Abeona Therapeutics Inc. | 252.16M | -0.67% | 1,062,267 | 5.82M |
| 284 | TENX | Tenax Therapeutics, Inc. | 247.65M | 0.70% | 194,537 | - |
| 285 | CLLS | Cellectis S.A. | 245.04M | -0.90% | 23,827 | 79.59M |
| 286 | CHRS | Coherus Oncology, Inc. | 239.07M | 4.93% | 582,815 | 42.17M |
| 287 | ELDN | Eledon Pharmaceuticals, Inc. | 237.80M | 8.85% | 1,292,461 | - |
| 288 | RZLT | Rezolute, Inc. | 234.46M | -1.61% | 523,939 | - |
| 289 | EDIT | Editas Medicine, Inc. | 234.40M | 2.35% | 837,803 | 40.52M |
| 290 | VYGR | Voyager Therapeutics, Inc. | 233.63M | 1.95% | 394,924 | 40.37M |
| 291 | HELP | Cybin Inc. | 229.16M | -0.87% | 417,947 | - |
| 292 | ALEC | Alector, Inc. | 228.45M | 0.98% | 254,147 | 21.05M |
| 293 | NVCT | Nuvectis Pharma, Inc. | 222.13M | 1.88% | 33,478 | - |
| 294 | KROS | Keros Therapeutics, Inc. | 220.24M | 1.92% | 264,298 | 244.06M |
| 295 | MDWD | MediWound Ltd. | 217.17M | -0.24% | 41,062 | 16.96M |
| 296 | SRZN | Surrozen, Inc. | 213.86M | -0.80% | 19,334 | 3.60M |
| 297 | ACHV | Achieve Life Sciences, Inc. | 212.40M | -0.25% | 415,743 | - |
| 298 | FENC | Fennec Pharmaceuticals Inc. | 209.19M | 1.64% | 103,860 | 38.79M |
| 299 | TNXP | Tonix Pharmaceuticals Holding Corp. | 208.05M | 3.47% | 290,194 | 13.11M |
| 300 | PRLD | Prelude Therapeutics Incorporated | 203.46M | 8.01% | 99,350 | 12.14M |
| 301 | ELTX | Elicio Therapeutics, Inc. | 201.25M | 0.83% | 68,317 | - |
| 302 | SLGL | Sol-Gel Technologies Ltd. | 199.91M | -1.67% | 12,108 | 19.39M |
| 303 | SABS | SAB Biotherapeutics, Inc. | 198.20M | 3.73% | 233,682 | 114.70K |
| 304 | CGEN | Compugen Ltd. | 195.75M | -0.94% | 121,817 | 72.76M |
| 305 | ARCT | Arcturus Therapeutics Holdings Inc. | 191.86M | 1.81% | 358,877 | 82.03M |
| 306 | CBUS | Cibus, Inc. | 190.29M | 10.89% | 354,512 | 3.64M |
| 307 | MGNX | MacroGenics, Inc. | 188.76M | 3.85% | 574,440 | 149.50M |
| 308 | GALT | Galectin Therapeutics Inc. | 185.04M | 4.36% | 76,363 | - |
| 309 | ZNTL | Zentalis Pharmaceuticals, Inc. | 183.16M | -3.24% | 240,350 | 26.87M |
| 310 | STRO | Sutro Biopharma, Inc. | 182.87M | 3.87% | 86,987 | 105.65M |
| 311 | NTHI | NeOnc Technologies Holdings, Inc. | 182.44M | 9.98% | 20,143 | 59.99K |
| 312 | CRBU | Caribou Biosciences, Inc. | 182.16M | 0.80% | 552,589 | 11.16M |
| 313 | WHWK | Whitehawk Therapeutics, Inc. | 177.46M | 4.74% | 42,480 | 7.15M |
| 314 | RNAC | Cartesian Therapeutics, Inc. | 176.55M | 2.30% | 57,260 | 2.80M |
| 315 | ADAG | Adagene Inc. | 175.09M | 2.34% | 74,862 | 103.20K |
| 316 | PLX | Protalix BioTherapeutics, Inc. | 174.11M | 1.17% | 698,988 | 52.74M |
| 317 | CNTN | Canton Strategic Holdings, Inc. | 172.07M | 0.45% | 203,508 | - |
| 318 | MOLN | Molecular Partners AG | 170.47M | -0.62% | 1,027 | 856.30K |
| 319 | VXRT | Vaxart, Inc. | 168.40M | 9.68% | 460,781 | 237.26M |
| 320 | ABOS | Acumen Pharmaceuticals, Inc. | 164.76M | 1.87% | 410,320 | - |
| 321 | DTIL | Precision BioSciences, Inc. | 162.83M | 1.00% | 151,987 | 34.26M |
| 322 | KRRO | Korro Bio, Inc. | 162.40M | 4.74% | 102,162 | 6.39M |
| 323 | PMN | ProMIS Neurosciences, Inc. | 161.73M | 2.47% | 4,905 | - |
| 324 | TNYA | Tenaya Therapeutics, Inc. | 161.69M | -0.81% | 2,119,039 | - |
| 325 | PRQR | ProQR Therapeutics N.V. | 161.20M | -0.65% | 149,779 | 19.19M |
| 326 | HUMA | Humacyte, Inc. | 159.72M | 8.94% | 10,121,989 | 1.57M |
| 327 | CNTB | Connect Biopharma Holdings Limited | 159.15M | 3.14% | 135,964 | 762.00K |
| 328 | EVAX | Evaxion A/S | 158.05M | -3.07% | 16,920 | 7.53M |
| 329 | SGMT | Sagimet Biosciences Inc. | 157.06M | - | 200,271 | - |
| 330 | NKTX | Nkarta, Inc. | 156.98M | 3.27% | 235,647 | - |
| 331 | IMUX | Immunic, Inc. | 155.25M | 8.18% | 1,491,876 | - |
| 332 | KLRS | Kalaris Therapeutics, Inc. | 153.98M | 2.22% | 22,187 | - |
| 333 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 151.29M | -0.81% | 84,080 | - |
| 334 | HRTX | Heron Therapeutics, Inc. | 150.08M | 2.23% | 686,249 | 154.90M |
| 335 | CDXS | Codexis, Inc. | 146.75M | 0.94% | 1,449,067 | 70.39M |
| 336 | VTVT | vTv Therapeutics Inc. | 145.42M | 2.56% | 32,269 | 17.00K |
| 337 | UNCY | Unicycive Therapeutics, Inc. | 145.07M | 0.30% | 172,371 | - |
| 338 | MENS | Jyong Biotech Ltd. | 144.01M | 14.12% | 116,979 | - |
| 339 | AGEN | Agenus Inc. | 143.23M | 0.54% | 228,775 | 114.20M |
| 340 | ORMP | Oramed Pharmaceuticals Inc. | 141.10M | 1.58% | 64,634 | 2.00M |
| 341 | FATE | Fate Therapeutics, Inc. | 138.35M | 8.18% | 1,195,340 | 6.65M |
| 342 | MIST | Milestone Pharmaceuticals Inc. | 134.09M | -2.94% | 2,427,734 | 1.55M |
| 343 | ANTX | AN2 Therapeutics, Inc. | 133.70M | -7.00% | 197,107 | - |
| 344 | SPRO | Spero Therapeutics, Inc. | 132.96M | -0.42% | 102,459 | 40.55M |
| 345 | ALDX | Aldeyra Therapeutics, Inc. | 132.40M | 21.55% | 5,166,210 | - |
| 346 | ARTV | Artiva Biotherapeutics, Inc. | 131.74M | 0.19% | 64,813 | 251.00K |
| 347 | IKT | Inhibikase Therapeutics, Inc. | 130.05M | -3.89% | 712,150 | 1.00 |
| 348 | KPTI | Karyopharm Therapeutics Inc. | 128.41M | -8.26% | 680,130 | 146.07M |
| 349 | VOR | Vor Biopharma Inc. | 127.43M | 1.66% | 671,296 | - |
| 350 | ACOG | Alpha Cognition Inc. | 126.43M | 1.84% | 36,515 | 7.43M |
| 351 | EQ | Equillium, Inc. | 125.14M | -3.52% | 230,808 | 4.39M |
| 352 | BDTX | Black Diamond Therapeutics, Inc. | 124.32M | 2.84% | 271,934 | 70.00M |
| 353 | IPHA | Innate Pharma S.A. | 123.71M | 12.82% | 54,625 | 14.84M |
| 354 | CRDF | Cardiff Oncology, Inc. | 122.72M | -0.28% | 272,066 | 593.00K |
| 355 | RANI | Rani Therapeutics Holdings, Inc. | 112.66M | 2.21% | 571,607 | 1.20M |
| 356 | GNLX | Genelux Corporation | 111.12M | 3.33% | 199,083 | 8.00K |
| 357 | INO | Inovio Pharmaceuticals, Inc. | 110.20M | 0.95% | 685,897 | 65.34K |
| 358 | SGMO | Sangamo Therapeutics, Inc. | 108.82M | -2.50% | 3,854,647 | 32.88M |
| 359 | QTTB | Q32 Bio Inc. | 108.70M | 11.23% | 381,273 | 53.74M |
| 360 | HURA | TuHURA Biosciences, Inc. | 106.10M | 6.70% | 586,832 | - |
| 361 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 103.72M | 10.95% | 988,060 | - |
| 362 | ONCY | Oncolytics Biotech Inc. | 102.29M | 0.06% | 342,892 | - |
| 363 | CGTX | Cognition Therapeutics, Inc. | 100.63M | 6.54% | 456,232 | - |
| 364 | TTRX | Turn Therapeutics Inc. | 100.11M | -1.16% | 1,412 | - |
| 365 | COYA | Coya Therapeutics, Inc. | 98.29M | -0.48% | 46,566 | 7.95M |
| 366 | SEER | Seer, Inc. | 96.20M | 1.49% | 128,214 | 16.58M |
| 367 | DWTX | Dogwood Therapeutics, Inc. | 95.53M | -4.67% | 21,945 | - |
| 368 | FBIO | Fortress Biotech, Inc. | 91.25M | -1.67% | 424,938 | 62.30M |
| 369 | PYXS | Pyxis Oncology, Inc. | 90.79M | -1.70% | 257,283 | 13.86M |
| 370 | GOSS | Gossamer Bio, Inc. | 89.28M | -9.94% | 20,815,821 | 48.47M |
| 371 | AARD | Aardvark Therapeutics, Inc. | 88.51M | -0.12% | 118,671 | - |
| 372 | VRCA | Verrica Pharmaceuticals Inc. | 86.92M | -7.16% | 98,529 | 35.58M |
| 373 | ANIX | Anixa Biosciences, Inc. | 86.17M | -3.02% | 86,960 | - |
| 374 | VANI | Vivani Medical, Inc. | 85.72M | 1.29% | 105,763 | - |
| 375 | SPRB | Spruce Biosciences, Inc. | 84.24M | 5.14% | 19,914 | 697.00K |
| 376 | MCRB | Seres Therapeutics, Inc. | 84.07M | 3.18% | 47,788 | 789.00K |
| 377 | CSBR | Champions Oncology, Inc. | 82.97M | 1.96% | 1,735 | 57.95M |
| 378 | CING | Cingulate Inc. | 82.91M | -3.39% | 408,200 | - |
| 379 | ATYR | aTyr Pharma, Inc. | 81.92M | 3.37% | 546,692 | 190.00K |
| 380 | NRXS | NeurAxis, Inc. | 81.67M | -4.20% | 211,627 | 3.57M |
| 381 | PLRX | Pliant Therapeutics, Inc. | 81.11M | 1.55% | 223,026 | - |
| 382 | KZIA | Kazia Therapeutics Limited | 80.41M | -1.34% | 15,047 | 1.20M |
| 383 | BMEA | Biomea Fusion, Inc. | 78.83M | -2.19% | 845,549 | - |
| 384 | PYPD | PolyPid Ltd. | 78.46M | 3.61% | 27,646 | - |
| 385 | PMVP | PMV Pharmaceuticals, Inc. | 77.74M | -0.83% | 167,825 | - |
| 386 | IBIO | iBio, Inc. | 77.72M | 7.66% | 416,852 | 300.00K |
| 387 | PTHS | Pelthos Therapeutics Inc. | 76.91M | 10.51% | 998 | 16.80M |
| 388 | MNOV | MediciNova, Inc. | 72.60M | -5.45% | 30,620 | 409.66K |
| 389 | XBIT | XBiotech Inc. | 72.41M | -0.63% | 41,454 | - |
| 390 | GANX | Gain Therapeutics, Inc. | 71.83M | 2.05% | 432,849 | - |
| 391 | IFRX | InflaRx N.V. | 71.80M | 5.66% | 127,282 | 34.44K |
| 392 | ANVS | Annovis Bio, Inc. | 71.46M | -3.08% | 223,584 | - |
| 393 | IBO | Impact BioMedical Inc. | 70.08M | -16.67% | 874,145 | 32.00K |
| 394 | GRCE | Grace Therapeutics, Inc. | 68.86M | 0.68% | 159,538 | - |
| 395 | COEP | Coeptis Therapeutics Holdings, Inc. | 68.45M | -2.66% | 12,228 | 1.36M |
| 396 | BYSI | BeyondSpring Inc. | 65.94M | 2.19% | 12,258 | 1.88M |
| 397 | ACET | Adicet Bio, Inc. | 63.94M | -3.71% | 126,651 | - |
| 398 | EDSA | Edesa Biotech, Inc. | 62.44M | 1.77% | 835,686 | - |
| 399 | IMA | ImageneBio, Inc. | 62.22M | 2.64% | 8,511 | 800.00K |
| 400 | ACRV | Acrivon Therapeutics, Inc. | 61.99M | -3.61% | 303,056 | - |
| 401 | EXOZ | eXoZymes, Inc. | 60.81M | 0.55% | 951 | -700.00 |
| 402 | ATHE | Alterity Therapeutics Limited | 60.45M | 1.37% | 1,287 | 4.43M |
| 403 | HYFT | MindWalk Holdings Corp. | 59.64M | 3.53% | 83,123 | 20.70M |
| 404 | GUTS | Fractyl Health, Inc. | 58.93M | -2.56% | 2,322,743 | 3.00K |
| 405 | TCRX | TScan Therapeutics, Inc. | 58.89M | -0.48% | 493,247 | 10.33M |
| 406 | IMMP | Immutep Limited | 55.89M | -3.53% | 691,947 | 5.28M |
| 407 | TIL | Instil Bio, Inc. | 55.61M | -4.09% | 9,297 | - |
| 408 | ACTU | Actuate Therapeutics, Inc. | 55.32M | 1.28% | 25,417 | - |
| 409 | ICCC | ImmuCell Corporation | 54.91M | 3.81% | 225 | 27.64M |
| 410 | MREO | Mereo BioPharma Group plc | 54.73M | 0.26% | 888,748 | 500.00K |
| 411 | OKUR | OnKure Therapeutics, Inc. | 54.72M | -4.49% | 104,267 | - |
| 412 | RADX | Radiopharm Theranostics Limited | 54.70M | -3.44% | 9,136 | 10.86M |
| 413 | OSTX | OS Therapies Incorporated | 54.23M | - | 419,537 | - |
| 414 | LPCN | Lipocine Inc. | 54.09M | 3.64% | 63,809 | 1.98M |
| 415 | MGX | Metagenomi Therapeutics, Inc. | 53.99M | 1.06% | 133,030 | 25.21M |
| 416 | MAIA | MAIA Biotechnology, Inc. | 53.70M | -0.68% | 208,736 | - |
| 417 | NRXP | NRx Pharmaceuticals, Inc. | 48.89M | -5.95% | 577,953 | 242.00K |
| 418 | RLYB | Rallybio Corporation | 48.69M | 3.78% | 50,972 | 858.00K |
| 419 | DCOY | Decoy Therapeutics Inc. | 48.49M | 1.74% | 4,312 | - |
| 420 | ENTX | Entera Bio Ltd. | 47.23M | -7.21% | 663,056 | 124.00K |
| 421 | KZR | Kezar Life Sciences, Inc. | 47.16M | 0.16% | 8,207 | - |
| 422 | ATOS | Atossa Therapeutics, Inc. | 47.10M | 2.63% | 29,146 | - |
| 423 | NTRB | Nutriband Inc. | 46.03M | 3.66% | 8,061 | 2.28M |
| 424 | XLO | Xilio Therapeutics, Inc. | 45.88M | 0.95% | 27,488 | 43.77M |
| 425 | LSTA | Lisata Therapeutics, Inc. | 45.25M | - | 48,527 | 170.00K |
| 426 | GOVX | GeoVax Labs, Inc. | 43.89M | -0.68% | 77,686 | 3.35M |
| 427 | LITS | Lite Strategy, Inc. | 43.63M | 2.56% | 91,215 | - |
| 428 | TELO | Telomir Pharmaceuticals, Inc. | 43.32M | -4.55% | 39,073 | - |
| 429 | PSTV | Plus Therapeutics, Inc. | 43.10M | 1.35% | 1,880,698 | 5.21M |
| 430 | ALGS | Aligos Therapeutics, Inc. | 42.94M | 1.91% | 16,248 | 2.19M |
| 431 | INKT | MiNK Therapeutics, Inc. | 42.25M | -4.36% | 42,655 | - |
| 432 | SNSE | Sensei Biotherapeutics, Inc. | 41.66M | 4.63% | 56,631 | - |
| 433 | PTN | Palatin Technologies, Inc. | 41.63M | -3.36% | 5,549 | 8.96M |
| 434 | ATRA | Atara Biotherapeutics, Inc. | 40.07M | -0.20% | 47,589 | 120.77M |
| 435 | HOWL | Werewolf Therapeutics, Inc. | 39.32M | 3.05% | 100,232 | 1.14M |
| 436 | ESLA | Estrella Immunopharma, Inc. | 38.95M | -0.82% | 62,765 | - |
| 437 | APLM | Apollomics, Inc. | 38.24M | -3.68% | 1,552 | 6.93M |
| 438 | RNXT | RenovoRx, Inc. | 37.75M | 3.00% | 327,565 | 928.00K |
| 439 | CRVO | CervoMed Inc. | 37.50M | 0.75% | 16,223 | 4.01M |
| 440 | NBY | NovaBay Pharmaceuticals, Inc. | 37.01M | 19.83% | 902,456 | 10.30M |
| 441 | VERU | Veru Inc. | 36.93M | 1.36% | 13,779 | 16.89M |
| 442 | CELU | Celularity Inc. | 35.76M | 1.64% | 27,492 | 40.58M |
| 443 | LONA | LeonaBio, Inc. | 35.53M | -9.17% | 51,266 | - |
| 444 | ATNM | Actinium Pharmaceuticals, Inc. | 35.41M | 2.25% | 293,491 | 90.00K |
| 445 | NXTC | NextCure, Inc. | 35.16M | -1.15% | 7,863 | - |
| 446 | TVRD | Tvardi Therapeutics, Inc. | 33.96M | 2.84% | 27,792 | - |
| 447 | SER | Serina Therapeutics, Inc. | 33.59M | 24.02% | 9,262,136 | 116.00K |
| 448 | JSPR | Jasper Therapeutics, Inc. | 33.30M | -3.25% | 177,480 | - |
| 449 | CMMB | Chemomab Therapeutics Ltd. | 33.21M | -9.83% | 60,329 | - |
| 450 | RNTX | Rein Therapeutics Inc. | 32.33M | -0.81% | 17,736 | - |
| 451 | INMB | INmune Bio Inc. | 32.17M | 3.42% | 390,392 | 50.00K |
| 452 | DYAI | Dyadic International, Inc. | 32.07M | -5.72% | 73,910 | 3.34M |
| 453 | ABVC | ABVC BioPharma, Inc. | 31.80M | 2.46% | 20,090 | 797.92K |
| 454 | TLSA | Tiziana Life Sciences Ltd | 31.37M | 9.09% | 255,145 | - |
| 455 | PLUR | Pluri Inc. | 30.76M | -1.61% | 21,269 | 1.34M |
| 456 | BCTX | BriaCell Therapeutics Corp. | 30.13M | 0.96% | 127,141 | - |
| 457 | CVM | CEL-SCI Corporation | 28.76M | -1.16% | 33,951 | - |
| 458 | KYNB | Kyntra Bio, Inc. | 28.73M | -0.42% | 28,212 | 6.44M |
| 459 | XCUR | Exicure, Inc. | 28.49M | 0.45% | 20,099 | 500.00K |
| 460 | HYPD | Hyperion DeFi, Inc. | 27.84M | 5.15% | 162,853 | 345.32K |
| 461 | PDSB | PDS Biotechnology Corporation | 27.53M | -1.58% | 214,953 | - |
| 462 | OTLK | Outlook Therapeutics, Inc. | 27.42M | -5.98% | 816,940 | 205.70K |
| 463 | NRSN | NeuroSense Therapeutics Ltd. | 26.55M | 5.56% | 27,134 | - |
| 464 | ENLV | Enlivex Ltd. | 26.24M | 7.84% | 223,593 | - |
| 465 | BOLD | Boundless Bio, Inc. | 25.88M | -2.94% | 39,254 | - |
| 466 | IGC | IGC Pharma, Inc. | 25.34M | -4.65% | 147,144 | 1.11M |
| 467 | BRNS | Barinthus Biotherapeutics plc | 24.92M | -3.17% | 1,860 | 14.97M |
| 468 | NEUP | Neuphoria Therapeutics Inc. | 24.58M | -1.08% | 45,064 | 14.99M |
| 469 | VTGN | Vistagen Therapeutics, Inc. | 24.42M | 1.20% | 205,305 | 789.00K |
| 470 | LTRN | Lantern Pharma Inc. | 24.27M | 1.88% | 10,663 | - |
| 471 | CUE | Cue Biopharma, Inc. | 23.67M | -8.80% | 957,137 | 27.47M |
| 472 | SNTI | Senti Biosciences, Inc. | 23.48M | -2.91% | 26,173 | - |
| 473 | TPST | Tempest Therapeutics, Inc. | 23.46M | -24.02% | 263,553 | - |
| 474 | PASG | Passage Bio, Inc. | 22.26M | -6.59% | 46,520 | - |
| 475 | MRKR | Marker Therapeutics, Inc. | 22.18M | -0.75% | 57,701 | 3.55M |
| 476 | LGVN | Longeveron Inc. | 21.79M | -4.44% | 523,846 | 1.20M |
| 477 | SKYE | Skye Bioscience, Inc. | 21.63M | -0.17% | 92,827 | - |
| 478 | NNVC | NanoViricides, Inc. | 21.43M | -3.64% | 117,608 | - |
| 479 | VYNE | VYNE Therapeutics Inc. | 19.99M | -3.95% | 52,311 | 570.00K |
| 480 | DARE | Daré Bioscience, Inc. | 19.36M | -0.37% | 63,994 | -57.13K |
| 481 | LEXX | Lexaria Bioscience Corp. | 17.71M | -0.24% | 28,259 | 522.00K |
| 482 | KTTA | Pasithea Therapeutics Corp. | 17.49M | -4.97% | 28,306 | - |
| 483 | TRAW | Traws Pharma, Inc. | 17.42M | 1.87% | 21,167 | 2.85M |
| 484 | ALLR | Allarity Therapeutics, Inc. | 17.39M | 1.85% | 60,381 | - |
| 485 | FBLG | FibroBiologics, Inc. | 17.05M | -0.71% | 415,965 | - |
| 486 | CTXR | Citius Pharmaceuticals, Inc. | 16.95M | -1.67% | 347,664 | 3.94M |
| 487 | INAB | IN8bio, Inc. | 16.40M | -16.75% | 205,787 | - |
| 488 | LIXT | Lixte Biotechnology Holdings, Inc. | 15.40M | -1.46% | 4,752 | - |
| 489 | AEON | AEON Biopharma, Inc. | 15.18M | 2.80% | 27,218 | - |
| 490 | INTS | Intensity Therapeutics, Inc. | 14.98M | -1.17% | 14,234 | - |
| 491 | PHIO | Phio Pharmaceuticals Corp. | 14.76M | 4.11% | 537,717 | - |
| 492 | COCP | Cocrystal Pharma, Inc. | 14.75M | 3.88% | 30,377 | - |
| 493 | GTBP | GT Biopharma, Inc. | 14.74M | 1.54% | 567,792 | - |
| 494 | HOTH | Hoth Therapeutics, Inc. | 14.38M | 1.33% | 85,593 | - |
| 495 | IOBT | IO Biotech, Inc. | 14.22M | 11.95% | 664,095 | - |
| 496 | PLRZ | Polyrizon Ltd. | 13.87M | 3.28% | 9,610 | - |
| 497 | ACXP | Acurx Pharmaceuticals, Inc. | 13.68M | -14.46% | 522,099 | - |
| 498 | CVKD | Cadrenal Therapeutics, Inc. | 13.58M | 0.31% | 48,627 | - |
| 499 | CLRB | Cellectar Biosciences, Inc. | 13.31M | -3.09% | 11,383 | - |
| 500 | JUNS | Jupiter Neurosciences, Inc. | 13.08M | -8.46% | 121,604 | - |
| 501 | QNRX | Quoin Pharmaceuticals, Ltd. | 12.73M | -0.79% | 4,646 | - |
| 502 | BCDA | BioCardia, Inc. | 12.68M | -0.42% | 40,102 | 3.00K |
| 503 | KAPA | Kairos Pharma, Ltd. | 12.08M | -3.24% | 82,828 | - |
| 504 | SNGX | Soligenix, Inc. | 12.00M | -0.83% | 52,365 | 2.34K |
| 505 | OSRH | OSR Holdings, Inc. | 11.90M | 6.06% | 8,659,792 | -90.52K |
| 506 | GNTA | Genenta Science S.p.A. | 11.87M | -1.67% | 97,748 | - |
| 507 | GDTC | CytoMed Therapeutics Limited | 11.77M | -7.27% | 9,812 | 573.19K |
| 508 | MBRX | Moleculin Biotech, Inc. | 11.26M | 2.43% | 47,835 | - |
| 509 | NCEL | NewcelX Ltd. | 10.94M | 1.27% | 5,537 | - |
| 510 | LNAI | Lunai Bioworks Inc. | 10.16M | -10.35% | 3,736,415 | - |
| 511 | BLRX | BioLineRx Ltd. | 10.12M | -12.26% | 62,560 | 12.74M |
| 512 | BCAB | BioAtla, Inc. | 10.07M | 1.54% | 177,241 | 11.00M |
| 513 | TOVX | Theriva Biologics, Inc. | 9.95M | 11.93% | 243,313,381 | - |
| 514 | CALC | CalciMedica, Inc. | 9.88M | 8.64% | 239,441 | - |
| 515 | CRIS | Curis, Inc. | 9.79M | -1.79% | 104,904 | 9.44M |
| 516 | BIVI | BioVie Inc. | 9.62M | 6.25% | 36,280 | - |
| 517 | IMNN | Imunon, Inc. | 9.03M | 2.44% | 23,040 | - |
| 518 | ITRM | Iterum Therapeutics plc | 9.01M | 5.83% | 268,580 | 390.00K |
| 519 | QNTM | Quantum BioPharma Ltd. | 8.69M | 33.93% | 265,524 | - |
| 520 | BOLT | Bolt Biotherapeutics, Inc. | 8.53M | -6.72% | 14,922 | 7.70M |
| 521 | PULM | Pulmatrix, Inc. | 8.49M | -6.63% | 9,195 | 3.00K |
| 522 | RNAZ | TransCode Therapeutics, Inc. | 8.48M | 3.01% | 5,383 | - |
| 523 | APM | Aptorum Group Limited | 8.25M | 20.37% | 416,763 | - |
| 524 | APRE | Aprea Therapeutics, Inc. | 8.16M | -6.55% | 59,402 | 285.76K |
| 525 | ICU | SeaStar Medical Holding Corporation | 8.15M | 1.35% | 49,375 | 881.00K |
| 526 | EVGN | Evogene Ltd. | 7.85M | 6.38% | 526,421 | 3.85M |
| 527 | CLGN | CollPlant Biotechnologies Ltd. | 7.73M | -1.61% | 7,769 | 2.48M |
| 528 | PMCB | PharmaCyte Biotech, Inc. | 7.62M | 3.38% | 142,910 | - |
| 529 | ADXN | Addex Therapeutics Ltd | 7.55M | 9.32% | 6,797 | 198.82K |
| 530 | PHGE | BiomX Inc. | 7.44M | -4.50% | 18,691 | - |
| 531 | KPRX | Kiora Pharmaceuticals, Inc. | 7.36M | -4.31% | 30,076 | 20.00K |
| 532 | SPRC | SciSparc Ltd. | 7.34M | -2.27% | 4,754 | 1.31M |
| 533 | ALZN | Alzamend Neuro, Inc. | 7.11M | 2.08% | 21,899 | - |
| 534 | TCRT | Alaunos Therapeutics, Inc. | 7.04M | -2.02% | 2,188 | 6.00K |
| 535 | XBIO | Xenetic Biosciences, Inc. | 6.99M | -6.44% | 10,046 | 2.98M |
| 536 | NCNA | NuCana plc | 6.97M | 1.52% | 33,355 | - |
| 537 | CDIO | Cardio Diagnostics Holdings, Inc. | 6.90M | 1.75% | 125,700 | 14.83K |
| 538 | CELZ | Creative Medical Technology Holdings, Inc. | 6.84M | 0.54% | 20,795 | 6.00K |
| 539 | GRDX | GridAI Technologies Corp. | 6.79M | -1.46% | 40,346 | - |
| 540 | ERNA | Ernexa Therapeutics Inc. | 6.70M | -13.47% | 2,331,208 | 1,000.00 |
| 541 | PCSA | Processa Pharmaceuticals, Inc. | 6.29M | 1.94% | 5,376 | - |
| 542 | CYCN | Cyclerion Therapeutics, Inc. | 6.10M | -2.20% | 10,200 | 2.86M |
| 543 | ARTL | Artelo Biosciences, Inc. | 6.00M | 2.26% | 359,726 | - |
| 544 | LIMN | Liminatus Pharma, Inc. | 5.74M | -0.02% | 456,529 | - |
| 545 | IMRN | Immuron Limited | 5.72M | -0.41% | 8,989 | 4.99M |
| 546 | MLEC | Moolec Science SA | 5.69M | -4.51% | 7,378 | 7.83M |
| 547 | PBM | Psyence Biomedical Ltd. | 5.60M | 1.73% | 12,759 | - |
| 548 | MBIO | Mustang Bio, Inc. | 5.55M | -2.68% | 18,933 | - |
| 549 | XTLB | XTL Biopharmaceuticals Ltd. | 5.16M | -0.75% | 7,261 | 968.00K |
| 550 | QNCX | Quince Therapeutics, Inc. | 4.91M | 10.25% | 7,695,522 | - |
| 551 | BGMS | Bio Green Med Solution, Inc. | 4.78M | 3.72% | 114,781 | 81.00K |
| 552 | AKTX | Akari Therapeutics, Plc | 4.76M | 2.31% | 169,316 | - |
| 553 | SILO | Silo Pharma, Inc. | 4.71M | -1.78% | 132,098 | 72.10K |
| 554 | AZTR | Azitra, Inc. | 4.62M | 0.85% | 20,402,451 | 7.50K |
| 555 | REVB | Revelation Biosciences, Inc. | 4.48M | 1.26% | 27,050 | - |
| 556 | BDRX | Biodexa Pharmaceuticals Plc | 4.46M | 2.77% | 77,261 | 104.90K |
| 557 | GNPX | Genprex, Inc. | 4.37M | 0.27% | 156,721 | - |
| 558 | VIVS | VivoSim Labs, Inc. | 4.30M | -1.79% | 59,859 | 142.00K |
| 559 | SLXN | Silexion Therapeutics Corp | 4.21M | 3.69% | 21,577 | - |
| 560 | APVO | Aptevo Therapeutics Inc. | 4.21M | -1.32% | 13,830 | - |
| 561 | MTNB | Matinas BioPharma Holdings, Inc. | 3.91M | -4.66% | 38,274 | - |
| 562 | ASBP | Aspire Biopharma Holdings, Inc. | 3.89M | 7.92% | 69,215 | 1.94K |
| 563 | INDP | Indaptus Therapeutics, Inc. | 3.83M | 0.59% | 8,172 | - |
| 564 | PPBT | Purple Biotech Ltd | 3.71M | 0.25% | 5,240 | - |
| 565 | GRI | GRI Bio, Inc. | 3.61M | 5.93% | 19,853 | - |
| 566 | XRTX | XORTX Therapeutics Inc. | 3.25M | -1.22% | 29,108 | - |
| 567 | GLMD | Galmed Pharmaceuticals Ltd. | 3.16M | -3.99% | 13,248 | - |
| 568 | OGEN | Oragenics, Inc. | 3.02M | -6.68% | 111,980 | - |
| 569 | ENVB | Enveric Biosciences, Inc. | 2.82M | -0.49% | 9,185 | - |
| 570 | BRTX | BioRestorative Therapies, Inc. | 2.68M | 8.00% | 1,547,272 | 383.40K |
| 571 | ADIL | Adial Pharmaceuticals, Inc. | 2.58M | -9.50% | 39,503 | - |
| 572 | BBLG | Bone Biologics Corporation | 2.15M | 3.45% | 1,228 | - |
| 573 | SCNI | Scinai Immunotherapeutics Ltd. | 2.15M | -3.62% | 22,980 | 1.15M |
| 574 | CLDI | Calidi Biotherapeutics, Inc. | 2.13M | 5.19% | 318,711 | - |
| 575 | ONCO | Onconetix, Inc. | 2.12M | -4.50% | 139,445 | 815.37K |
| 576 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.04M | -1.03% | 106,063 | 1.36M |
| 577 | KALA | KALA BIO, Inc. | 1.94M | -0.04% | 2,329,378 | - |
| 578 | ENSC | Ensysce Biosciences, Inc. | 1.88M | -8.89% | 279,926 | 4.49M |
| 579 | DRMA | Dermata Therapeutics, Inc. | 1.86M | 8.56% | 1,872,232 | - |
| 580 | PPCB | Propanc Biopharma, Inc. | 1.82M | 1.68% | 3,373,207 | - |
| 581 | HCWB | HCW Biologics Inc. | 1.64M | -32.40% | 2,043,581 | 422.03K |
| 582 | CNSP | CNS Pharmaceuticals, Inc. | 1.54M | 8.30% | 18,246 | - |
| 583 | JAGX | Jaguar Health, Inc. | 1.49M | -4.65% | 191,237 | 11.79M |
| 584 | CMND | Clearmind Medicine Inc. | 968.60K | -2.15% | 68,283 | - |
| 585 | OKYO | OKYO Pharma Limited | 926.90K | 2.55% | 36,515 | - |
| 586 | CDT | CDT Equity Inc. | 801.83K | 1.11% | 47,381 | - |
| 587 | VRAX | Virax Biolabs Group Limited | 781.12K | 3.87% | 62,264 | 2.99K |
| 588 | ADTX | Aditxt, Inc. | 615.39K | -15.38% | 147,915 | 5.95K |
| 589 | ELAB | PMGC Holdings Inc. | 310.62K | 5.11% | 20,890 | 285.95K |
| 590 | MTVA | MetaVia Inc. | 304.23K | 3.19% | 311,254 | - |
| 591 | CANF | Can-Fite BioPharma Ltd. | 18.55K | 2.84% | 25,330 | 560.00K |